Chimerix, Inc. (CMRX) financial statements (2021 and earlier)

Company profile

Business Address 2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC 27713
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments79113187152232220235
Cash and cash equivalents471781195121128
Short-term investments3297105133181200106
Receivables0102220
Prepaid expense0000001
Other current assets121111 
Other undisclosed current assets1112252
Total current assets:82118189157236229237
Noncurrent Assets
Operating lease, right-of-use asset31
Property, plant and equipment0112331
Long-term investments and receivables   774712453
Long-term investments   774712453
Other noncurrent assets0000000
Total noncurrent assets:311795012754
TOTAL ASSETS:85119191235287356292
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities991313102013
Accounts payable12544106
Accrued liabilities77896107
Debt      4
Total current liabilities:991313102017
Noncurrent Liabilities
Long-term debt and lease obligation3      
Operating lease, liability3 
Liabilities, other than long-term debt 000000
Deferred revenue and credits 0  
Other liabilities 000 00
Other undisclosed noncurrent liabilities(3)      
Total noncurrent liabilities:3000000
Total liabilities:1191313112117
Stockholders' equity
Stockholders' equity attributable to parent, including:73110178222276335275
Common stock      0
Additional paid in capital786779734710692676497
Accumulated other comprehensive income (loss) 0(0)(1)(0)(1)0
Accumulated deficit(712)(669)(556)(487)(416)(339)(222)
Other undisclosed stockholders' equity attributable to parent000000 
Total stockholders' equity:73110178222276335275
TOTAL LIABILITIES AND EQUITY:85119191235287356292

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net46114
Gross profit:513746114
Operating expenses(50)(129)(79)(77)(84)(129)(63)
Operating loss:(45)(116)(72)(72)(78)(118)(59)
Interest and debt expense     (0)(0)
Loss before gain (loss) on sale of properties:(45)(116)(72)(72)(78)(118)(59)
Other undisclosed net income (loss)132121(0)
Net loss available to common stockholders, diluted:(44)(113)(69)(71)(76)(117)(59)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(44)(113)(69)(71)(76)(117)(59)
Other comprehensive loss     (118)(59)
Comprehensive loss:(44)(113)(69)(71)(76)(236)(119)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)01(1)0  
Comprehensive loss, net of tax, attributable to parent:(44)(112)(69)(72)(76)(236)(119)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: